Sign up to see all 5.
None.
No insider has filed a notice of proposed sale (Form 144) for Odyssey Therapeutics Inc in the last 12 months.
There are not yet two fiscal years of reported share counts for Odyssey Therapeutics Inc.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
F
FMR LLC
|
5.2M | 10.78% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding5.2M (Q2'26)
Change over 8 quarters+5.2M
Share of the company10.780%
|
||||||
|
SO
SR One Capital Management, LP
|
3.8M | 7.90% | NEW | Q2 '26 | 6.8% | |
|
Shares held by quarter
Peak holding3.8M (Q2'26)
Change over 8 quarters+3.8M
Share of the company7.900%
|
||||||
23 more super investors behind a free account
See every manager holding Odyssey Therapeutics Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FG
Fidelity Mt. Vernon Street Trust
|
$27.1M | 1.1M | 2.30% | 0.03% | August 31, 2026 |
|
VT
Vanguard Index Funds
|
$9.94M | 531.1K | 1.11% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Odyssey Therapeutics Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SO
SR One Capital Management, LLC
5%+ holder
13D · 8.0%
|
3.8M | 7.90% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
JG
James G. Coulter
5%+ holder
13D · 7.8%
|
3.7M | 7.68% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
12 more holders behind a free account
See every insider and 5%+ holder of Odyssey Therapeutics Inc.
Sign up freeLoading...